-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on Surgery Partners, Maintains $19 Price Target

Benzinga·09/30/2026 13:10:21
Listen to the news
RBC Capital analyst Ben Hendrix reiterates Surgery Partners (NASDAQ:SGRY) with a Outperform and maintains $19 price target.